Industry, FDA Officials Sing Same Tune: Harmonize Quality by Design
This article was originally published in The Gold Sheet
Executive Summary
Singing the same tune officials with FDA and industry trumpet harmonized QbD.
You may also be interested in...
FDA Warns Against Using Compounded Remdesivir Due To Quality Concerns
Although compounding of certain shortage drugs is allowed during the public health emergency, remdesivir is off limits due to its complexity. Providers should only use the FDA-approved version of the drug, Gilead’s Veklury, the agency says.
US FDA Gives Industry An Extension On Nitrosamine Risk Assessments
Drug makers win one-month reprieve for their nitrosamine risk assessments for new drug products and approved products.
How Genentech Pivoted To Digital During The Pandemic
Technologies like head-mounted tablets became critical for method transfers, virtual inspections and more. Cloud-based submissions could be next …
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: